Rothfuss Cristin sold SRPT
March 9, 2026 · Form 4 insider transaction
Rothfuss Cristin sold 346 shares of Sarepta Therapeutics, Inc. at $16.95 per share, a transaction worth $5.9K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
346
Price
$16.95
Total value
$5.9K
InsiderRothfuss Cristin
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 9, 2026
Filing dateMarch 11, 2026
Shares owned after138,518
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.